Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Greenberg

Showing results (391-400 of 405) with videos related to

Pageof 41
Sort By:
Plos One|October 7, 2015
A Multicenter, Open-Label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA Smallpox Vaccine (IMVAMUNE) in 18-40 Year Old Subjects with Diagnosed Atopic DermatitisRichard N Greenberg, Maria Yadira Hurley, Yadira Hurley, et al.
Blood|January 29, 2021
T-cell activation profiles distinguish hemophagocytic lymphohistiocytosis and early sepsisVandana Chaturvedi, Rebecca A Marsh, Adi Zoref-Lorenz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 18, 2006
Safety of long-term oral posaconazole use in the treatment of refractory invasive fungal infectionsIssam I Raad, John R Graybill, Ana Beatriz Bustamante, et al.
Antimicrobial Agents and Chemotherapy|December 27, 2005
Posaconazole as salvage therapy for zygomycosisR N Greenberg, K Mullane, J-A H van Burik, et al.
BMJ Military Health|June 15, 2022
Addressing moral injury in the militaryAndrea J Phelps, A B Adler, S A H Belanger, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 14, 2018
Detecting Infections Rapidly and Easily for Candidemia Trial, Part 2 (DIRECT2): A Prospective, Multicenter Study of the T2Candida PanelCornelius J Clancy, Peter G Pappas, Jose Vazquez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 9, 2026
Safety, Efficacy, and Immunogenicity of a Multivalent Adjuvanted S. aureus Vaccine in Adults with Recent Skin And Soft Tissue Infections: An Observer-blind, Randomized, Placebo-controlled, Multinational Phase 1/2 TrialEugene Athan, Richard N Greenberg, David A Baker, et al.
Annals of Internal Medicine|May 5, 2010
Safety of herpes zoster vaccine in the shingles prevention study: a randomized trialMichael S Simberkoff, Robert D Arbeit, Gary R Johnson, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 24, 2017
Manipulating DNA damage-response signaling for the treatment of immune-mediated diseasesJonathan P McNally, Scott H Millen, Vandana Chaturvedi, et al.
AIDS (London, England)|April 7, 2007
Efficacy and safety of etravirine (TMC125) in patients with highly resistant HIV-1: primary 24-week analysis, Jeffrey P Nadler, Daniel S Berger, et al.
Pageof 41

Showing results (391-400 of 405) with videos related to

Sort By:
Pageof 41
Plos One|October 7, 2015
A Multicenter, Open-Label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA Smallpox Vaccine (IMVAMUNE) in 18-40 Year Old Subjects with Diagnosed Atopic DermatitisRichard N Greenberg, Maria Yadira Hurley, Yadira Hurley, et al.
Blood|January 29, 2021
T-cell activation profiles distinguish hemophagocytic lymphohistiocytosis and early sepsisVandana Chaturvedi, Rebecca A Marsh, Adi Zoref-Lorenz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 18, 2006
Safety of long-term oral posaconazole use in the treatment of refractory invasive fungal infectionsIssam I Raad, John R Graybill, Ana Beatriz Bustamante, et al.
Antimicrobial Agents and Chemotherapy|December 27, 2005
Posaconazole as salvage therapy for zygomycosisR N Greenberg, K Mullane, J-A H van Burik, et al.
BMJ Military Health|June 15, 2022
Addressing moral injury in the militaryAndrea J Phelps, A B Adler, S A H Belanger, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 14, 2018
Detecting Infections Rapidly and Easily for Candidemia Trial, Part 2 (DIRECT2): A Prospective, Multicenter Study of the T2Candida PanelCornelius J Clancy, Peter G Pappas, Jose Vazquez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 9, 2026
Safety, Efficacy, and Immunogenicity of a Multivalent Adjuvanted S. aureus Vaccine in Adults with Recent Skin And Soft Tissue Infections: An Observer-blind, Randomized, Placebo-controlled, Multinational Phase 1/2 TrialEugene Athan, Richard N Greenberg, David A Baker, et al.
Annals of Internal Medicine|May 5, 2010
Safety of herpes zoster vaccine in the shingles prevention study: a randomized trialMichael S Simberkoff, Robert D Arbeit, Gary R Johnson, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 24, 2017
Manipulating DNA damage-response signaling for the treatment of immune-mediated diseasesJonathan P McNally, Scott H Millen, Vandana Chaturvedi, et al.
AIDS (London, England)|April 7, 2007
Efficacy and safety of etravirine (TMC125) in patients with highly resistant HIV-1: primary 24-week analysis, Jeffrey P Nadler, Daniel S Berger, et al.
Pageof 41